Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

XELJANZ / XELJANZ XR How Supplied/Storage and Handling (tofacitinib)

16 HOW SUPPLIED/STORAGE AND HANDLING

Bottle Size
(number of tablets)
NDC Number
XELJANZ
5 mg tofacitinib tablets

White, round, immediate-release film-coated tablets, debossed with "Pfizer" on one side, and "JKI 5" on the other side
28NDC 0069-1001-03
60NDC 0069-1001-01
XELJANZ
10 mg tofacitinib tablets

Blue, round, immediate-release film-coated tablets, debossed with "Pfizer" on one side, and "JKI 10" on the other side
28NDC 0069-1002-03
60NDC 0069-1002-01
180NDC 0069-1002-02
XELJANZ XR
11 mg tofacitinib tablets

Pink, oval, extended-release film-coated tablets with a drilled hole at one end of the tablet band and "JKI 11" printed on one side of the tablet
14NDC 0069-0501-14
30NDC 0069-0501-30
XELJANZ XR
22 mg tofacitinib tablets

Beige, oval, extended-release film-coated tablets with a drilled hole at one end of the tablet band and "JKI 22" printed on one side of the tablet
30NDC 0069-0502-30

Store XELJANZ/XELJANZ XR at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature].

XELJANZ/XELJANZ XR

Do not repackage.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch